Loss of PDEF, a prostate-derived Ets factor is associated with aggressive phenotype of prostate cancer: regulation of MMP 9 by PDEF.
about
Mechanisms underlying the anti-tumoral effects of Citrus Bergamia juiceProstate-derived Ets transcription factor (PDEF) is a potential prognostic marker in patients with prostate cancerSPDEF inhibits prostate carcinogenesis by disrupting a positive feedback loop in regulation of the Foxm1 oncogene.Prostate-Derived ETS Factor Regulates Epithelial-to-Mesenchymal Transition through Both SLUG-Dependent and Independent MechanismsMechanisms and functional consequences of PDEF protein expression loss during prostate cancer progression.High SPDEF may identify patients who will have a prolonged response to androgen deprivation therapy.Relative mRNA expression of prostate-derived E-twenty-six factor and E-twenty-six variant 4 transcription factors, and of uridine phosphorylase-1 and thymidine phosphorylase enzymes, in benign and malignant prostatic tissue.Oncogenic activation in prostate cancer progression and metastasis: Molecular insights and future challenges.Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)-Troglitazone-induced Apoptosis in Prostate Cancer Cells Involve AMP-activated Protein Kinase.The transcription factor SPDEF suppresses prostate tumor metastasisSecreted Hsp90 is a novel regulator of the epithelial to mesenchymal transition (EMT) in prostate cancer.Locus-specific gene repositioning in prostate cancerThe transcription factor sterile alpha motif (SAM) pointed domain-containing ETS transcription factor (SPDEF) is required for E-cadherin expression in prostate cancer cells.PDEF promotes luminal differentiation and acts as a survival factor for ER-positive breast cancer cells.GADD45α and γ interaction with CDK11p58 regulates SPDEF protein stability and SPDEF-mediated effects on cancer cell migrationSPDEF functions as a colorectal tumor suppressor by inhibiting β-catenin activity.PDEF in prostate cancer.Roles of matrix metalloproteinases and their natural inhibitors in prostate cancer progression.Signatures of prostate-derived Ets factor (PDEF) in cancer.A short-term intervention with selenium affects expression of genes implicated in the epithelial-to-mesenchymal transition in the prostate.The androgen-induced protein AIbZIP facilitates proliferation of prostate cancer cells through downregulation of p21 expression.Upregulation of prostate-derived Ets factor by luteolin causes inhibition of cell proliferation and cell invasion in prostate carcinoma cells.SPDEF: a molecular switch for E-cadherin expression that promotes prostate cancer metastasis.A tight junction between E-Cadherin and the prostate tumor suppressor SPDEFMolecular markers for prostate cancer in formalin-fixed paraffin-embedded tissues.Eukaryotic Translation Initiation Factor 4 Gamma 1 (eIF4G1) is upregulated during Prostate cancer progression and modulates cell growth and metastasis.Analysis of select members of the E26 (ETS) transcription factors family in colorectal cancer.ELF3, ELF5, EHF and SPDEF Transcription Factors in Tissue Homeostasis and CancerTumor Cell-educated Periprostatic Adipose Tissue Acquires an Aggressive Cancer-promoting Secretory Profile
P2860
Q21133561-944B1CD7-FC5B-463D-BEB4-717A92255E4AQ24306191-44942DFB-A19A-4C33-A060-17174A491392Q34257025-E3B6348C-CB9F-4450-9842-63C587F24F1BQ35034883-3004494A-7FAC-46FB-A7CD-041D1DF8C8F1Q35082366-B5214087-FAF9-491B-AB14-8B040A550BADQ35539939-D776ACF2-2DF0-415D-AFC2-3414B79401DBQ35758944-B8147A68-8A5B-4688-9F54-63E8D9EC9370Q35838821-D3CE80BC-D0B7-4C93-BD36-37DABC354D0EQ36065205-958B635D-4B4D-4DB0-977A-4FAFD6556ABBQ36215965-4C949EFD-88B0-499C-9563-7825ADF321A2Q36368188-1D88D82A-D77E-4F16-A27B-D4ACC529241EQ36463336-D17720C7-B631-4207-9FFC-FF7C7C95EE08Q36796922-21439759-6571-46F1-8169-B0DBDA15500BQ37011750-19DE3525-563C-4073-8BB7-C30977D7B87AQ37046475-F4CE8DE9-83DC-4D11-BCB3-B14264BA7C0BQ37081755-ECC29D99-2D60-4B46-B257-32F8699AC550Q37907174-A6D7B398-FF36-4067-9611-3C6169E520EFQ38224605-054C0472-7EF9-41C5-9211-BE6388ADBB5FQ38747388-2813E36A-5FD7-4669-9EC0-08B12D70A6D6Q39027111-02B59940-E8FD-4FE7-9ED2-07F2F6FECF8BQ39182146-AA92DD4B-B10A-4AC6-B0DF-371E29C59AF9Q39502702-735CDA5A-A8E9-4743-996B-36630A5D1DD9Q41833246-0EDF4014-0099-41C9-B547-9CD967BCA32EQ41863094-AD933220-6141-4E1B-9C15-8DC92759785EQ42184292-DC0865C1-00AD-4830-858A-1FA4E9814CD0Q53684290-6F8DFFF8-0DD5-4104-AD32-C6898F8D7B24Q54387889-E4E87CFE-3989-4044-8B80-F66BE0F5B35FQ58696663-0834965C-1D0B-4A8C-8BD3-DE9A87370FC3Q58835433-C415312F-E8D4-4742-9653-634B277C6CAF
P2860
Loss of PDEF, a prostate-derived Ets factor is associated with aggressive phenotype of prostate cancer: regulation of MMP 9 by PDEF.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Loss of PDEF, a prostate-deriv ...... : regulation of MMP 9 by PDEF.
@en
Loss of PDEF, a prostate-deriv ...... : regulation of MMP 9 by PDEF.
@nl
type
label
Loss of PDEF, a prostate-deriv ...... : regulation of MMP 9 by PDEF.
@en
Loss of PDEF, a prostate-deriv ...... : regulation of MMP 9 by PDEF.
@nl
prefLabel
Loss of PDEF, a prostate-deriv ...... : regulation of MMP 9 by PDEF.
@en
Loss of PDEF, a prostate-deriv ...... : regulation of MMP 9 by PDEF.
@nl
P2093
P2860
P356
P1433
P1476
Loss of PDEF, a prostate-deriv ...... : regulation of MMP 9 by PDEF.
@en
P2093
Binod Kumar
Hari K Koul
Lakshmipathi Khandrika
Paul D Maroni
Randall B Meacham
Sarah Venezia
Sweaty Koul
Thomas R Johnson
P2860
P2888
P356
10.1186/1476-4598-9-148
P577
2010-06-15T00:00:00Z
P5875
P6179
1035286848